Apr 14, 2024 · When given alone or with chemo, Herceptin can help to slow the growth of HER2-positive breast cancer. Studies have shown that it improves survival in advanced breast cancers with extra...

Learn about dosing of Herceptin® (trastuzumab) for your patients with HER2+ Adjuvant Breast Cancer. See Full Safety and Boxed Warnings for more information.

Oct 22, 2024 · Targeted Therapy: Herceptin. Trastuzumab (Herceptin) was the first targeted therapy approved by the FDA for HER2+ breast cancer. It’s a type of biologic drug called a monoclonal antibody.

Find information about Herceptin® (trastuzumab), a treatment for HER2+ early and metastatic breast cancer and stomach cancer/GEJ. See full safety & Boxed Warnings for more information.

Trastuzumab is a monoclonal antibody targeting HER2, inducing an immune-mediated response that causes internalization and recycling of HER2. It may also upregulate cell cycle inhibitors such as p21 Waf1 and p27 Kip1 .

Herceptin (trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. Learn more.

Herceptin is indicated for adjuvant treatment of HER2-overexpressing node-positive or node-negative (ER/PR-negative or with one high-risk feature ‡) breast cancer: Select patients for therapy based on an FDA-approved companion diagnostic for Herceptin.

Jul 24, 2024 · The first HER2-targeted therapy, trastuzumab (Herceptin) combined with chemotherapy, improved overall survival outcomes of these cancers by 30% and reduced the risk of recurrence by 50%, says Mayo Clinic oncologist Ciara O’Sullivan, M.B., B.Ch.

Nov 7, 2024 · Herceptin, a HER2 inhibitor targeted therapy, treats breast cancer. Learn if it's right for you and more here. This monoclonal antibody has been an effective tool in treating breast cancer for ...

Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes.